Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6069)
All Articles published online
|
Publishing Process of This Article
|
Nov 27, 2018 (publication date) through Jun 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xi SY, Minuk GY. Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma. World J Hepatol 2018; 10(11): 799-806 [PMID: 30533181 DOI: 10.4254/wjh.v10.i11.799] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v10/i11/799.htm |
| Number | Citing Articles |
| 1 |
Yongjie Niu, Liang Shan, Han Gao, Congcong Zhang, Zijun Qian, Zhixian Wang, Xin Xu, Xiao Zhang, Jiayi Wang, Lifang Ma, Liyun Chen, Yongchun Yu. <p>Huaier Suppresses the Hepatocellular Carcinoma Cell Cycle by Regulating Minichromosome Maintenance Proteins</p>. OncoTargets and Therapy 2020; : 12015 doi: 10.2147/OTT.S279723
|
| 2 |
Xiaobin Zao, Xu Cao, Yijun Liang, Jiaxin Zhang, Hening Chen, Ningyi Zhang, Ruijia Liu, Qian Jin, Yue Chen, Xiaoke Li, Hongbo Du, Guang Chen, Li Hou, Yong'an Ye. The Chinese herbal KangXianYiAi formula inhibits hepatocellular carcinoma by reducing glutathione and inducing ferroptosis. Pharmacological Research - Modern Chinese Medicine 2023; 8: 100276 doi: 10.1016/j.prmcm.2023.100276
|
| 3 |
Zhulin Wu, Li He, Lianan Wang, Lisheng Peng. Systematically Exploring the Antitumor Mechanisms of Core Chinese Herbs on Hepatocellular Carcinoma: A Computational Study. Evidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/2396569
|
| 4 |
Fuu-Jen Tsai, Xiang Liu, Chao-Jung Chen, Te-Mao Li, Jian-Shiun Chiou, Po-Heng Chuang, Cheng-Hang Ko, Ting-Hsu Lin, Chiu-Chu Liao, Shao-Mei Huang, Wen-Miin Liang, Ying-Ju Lin. Chinese herbal medicine therapy and the risk of overall mortality for patients with liver cancer who underwent surgical resection in Taiwan. Complementary Therapies in Medicine 2019; 47: 102213 doi: 10.1016/j.ctim.2019.102213
|
| 5 |
Sidra Khan, Alanah Varricchio, Carmela Ricciardelli, Andrea J. Yool. Invasiveness of endometrial cancer cell lines is potentiated by estradiol and blocked by a traditional medicine Guizhi Fuling at clinically relevant doses. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1015708
|
| 6 |
Chuihua Sun, Fang Dong, Ting Xiao, Wenni Gao. Efficacy and safety of Chinese patent medicine (Kang-ai injection) as an adjuvant in the treatment of patients with hepatocellular carcinoma: a meta-analysis. Pharmaceutical Biology 2021; 59(1): 470 doi: 10.1080/13880209.2021.1915340
|
| 7 |
Wei‐Shu Wang, Yu‐Shan Chen, Chen‐Yu Kuo, Jai‐Jen Tsai, Fei‐Ting Hsu, Jing‐Gung Chung, Po‐Jung Pan.
DNA
damage and
NF‐κB
inactivation implicate glycyrrhizic acid‐induced
G
1
phase arrest in hepatocellular carcinoma cells
. Journal of Food Biochemistry 2022; 46(7) doi: 10.1111/jfbc.14128
|
| 8 |
Yinjie Fan, Hang Xue, Huachuan Zheng. Systemic Therapy for Hepatocellular Carcinoma: Current Updates and Outlook. Journal of Hepatocellular Carcinoma 2022; : 233 doi: 10.2147/JHC.S358082
|
| 9 |
Yuan Cai, Qing Du, Tian-Hao Deng, Bing-Bing Shen, Yan-Mei Peng, Pu-Hua Zeng, Song-Ren Yu, Yu CAI. Huxie Huaji Ointment Induced Apoptosis of Liver Cancer Cells In Vivo and In Vitro by Activating the Mitochondrial Pathway. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/9922059
|
| 10 |
Yuyao Li, Yue Li, Jinghao Zhang, Longshan Ji, Man Li, Xuehua Sun, Hai Feng, Zhuo Yu, Yueqiu Gao. Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 41 doi: 10.2147/JHC.S346047
|
| 11 |
Xiaonan Chen, Yanan Zhao, Ailin Yang, Yingying Tian, Daoran Pang, Jing Sun, Leimengyuan Tang, Huiming Huang, Ying Wang, Yunfang Zhao, Pengfei Tu, Zhongdong Hu, Jun Li. Chinese Dragon’s Blood EtOAc Extract Inhibits Liver Cancer Growth Through Downregulation of Smad3. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00669
|
| 12 |
Pan‐pan Feng, You‐kun Qi, Na Li, Hong‐rong Fei. Scutebarbatine A induces cytotoxicity in hepatocellular carcinoma via activation of the MAPK and ER stress signaling pathways. Journal of Biochemical and Molecular Toxicology 2021; 35(5) doi: 10.1002/jbt.22731
|
| 13 |
Chao Liu, Renwei Huang, Han Yu, Yanju Gong, Peijie Wu, Quansheng Feng, Xia Li. Fuzheng Xiaozheng prescription exerts anti-hepatocellular carcinoma effects by improving lipid and glucose metabolisms via regulating circRNA-miRNA-mRNA networks. Phytomedicine 2022; 103: 154226 doi: 10.1016/j.phymed.2022.154226
|
| 14 |
Yuting Hu, Wei Qiu, Zhijun Kong, Siyuan Wu, Yi Liu, Chunfu Zhu, Xihu Qin, Aaron Bell. LncRNA GSTM3TV2 Promotes Cell Proliferation and Invasion via miR-597/FOSL2 Axis in Hepatocellular Carcinoma. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/3445970
|
| 15 |
Pei-Li Zhu, Jun-Kui Li, Xiao-Li Jiang, Shi-Qing Zhang, Zhu Zhang, Ying Wang, Zhang Zhang, Wen-Qing Chen, Ken-Kin-Lam Yung. A traditional prescription comprising Astragali Radix and Schisandra chinensis Fructus induces apoptosis and protective autophagy in hepatocellular carcinoma cells. Journal of Ethnopharmacology 2023; 312: 116548 doi: 10.1016/j.jep.2023.116548
|
| 16 |
Simo Cheng, Hetong Zhao, Yongbin Meng, Yuyu Guo, Man Yao, Xiaowan Xu, Xiaofeng Zhai, Changquan Ling. Impact of treatment-duration-ratio of traditional Chinese medicine on survival period of primary liver cancer —A real-world study. Heliyon 2022; 8(12): e12358 doi: 10.1016/j.heliyon.2022.e12358
|
| 17 |
Chao Wang, Lili Yang, Shaoheng Xu, Hui Guo, Hewen Guan, Qiannan Wang, Xueyan Jiang, Mingyang Fei, Jinbao Zhang. Systematic analysis of the role and significance of target genes of active ingredients of traditional Chinese medicine injections in the progression and immune microenvironment of hepatocellular carcinoma. Frontiers in Pharmacology 2023; 13 doi: 10.3389/fphar.2022.1095965
|
| 18 |
Teng Yong-Jiea, Liu Zhuob, Liao Liuc, Chen Yuanc, Huang Xiao-Did, Tian Xue-Feic. STAT3 Inhibition by Centipede Scolopendra Extract in Liver Cancer HepG2 Cells and Orthotopic Mouse Models of Hepatocellular Carcinoma. Digital Chinese Medicine 2020; 3(2): 67 doi: 10.1016/j.dcmed.2020.06.002
|
| 19 |
Caiyun Zhang, Hongjiao Xiang, Junmin Wang, Gaoxuan Shao, Peilun Ding, Ying Gao, Hanchen Xu, Guang Ji, Tao Wu. Exploring the mechanism of Jianpi Huatan recipe in protecting hepatocellular carcinoma based on network pharmacology. Journal of Ethnopharmacology 2023; 317: 116676 doi: 10.1016/j.jep.2023.116676
|
| 20 |
Zhijun Li, Haiying Bao. Comparative transcriptome and proteome analysis explores the antitumor key regulators of ergosterone in H22 tumor-bearing mice. European Journal of Pharmacology 2023; 953: 175831 doi: 10.1016/j.ejphar.2023.175831
|
| 21 |
Ruiyuan Jiang, Shujuan Luo, Meng Zhang, Wei Wang, Shaoyuan Zhuo, Yajing Wu, Qingmei Qiu, Yuan Yuan, Xiao Jiang. Ginsenoside Rh4 inhibits inflammation-related hepatocellular carcinoma progression by targeting HDAC4/IL-6/STAT3 signaling. Molecular Genetics and Genomics 2023; 298(6): 1479 doi: 10.1007/s00438-023-02070-w
|
| 22 |
Xia Liao, Yang Bu, Qingan Jia. Traditional Chinese medicine as supportive care for the management of liver cancer: Past, present, and future. Genes & Diseases 2020; 7(3): 370 doi: 10.1016/j.gendis.2019.10.016
|
| 23 |
He-tong Zhao, Yong-bin Meng, Xiao-feng Zhai, Bin-bin Cheng, Sha-sha Yu, Man Yao, Hui-xia Yin, Xu-ying Wan, Yun-ke Yang, Hui Liu, Feng Shen, Chang-quan Ling. Comparable effects of Jiedu Granule, a compound Chinese herbal medicine, and sorafenib for advanced hepatocellular carcinoma: A prospective multicenter cohort study. Journal of Integrative Medicine 2020; 18(4): 319 doi: 10.1016/j.joim.2020.05.003
|
| 24 |
Sa Guo, Nan Xing, Qinyun Du, Bin Luo, Shaohui Wang. Deciphering hepatocellular carcinoma pathogenesis and therapeutics: a study on anoikis, ceRNA regulatory network and traditional Chinese medicine. Frontiers in Pharmacology 2024; 14 doi: 10.3389/fphar.2023.1325992
|
| 25 |
Xu Cao, Hening Chen, Zhiguo Li, Xiaoke Li, Xianzhao Yang, Qiushuo Jin, Yijun Liang, Jiaxin Zhang, Meiyue Zhou, Ningyi Zhang, Guang Chen, Hongbo Du, Xiaobin Zao, Yong’an Ye. Network pharmacology and in vitro experiments-based strategy to investigate the mechanisms of KangXianYiAi formula for hepatitis B virus-related hepatocellular carcinoma. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.985084
|
| 26 |
Jia Yan, Xiu ling Deng, Shi qi Ma, Yu hui Li, Yu min Gao, Gui tao Shi, Hai sheng Wang. Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response. BMC Complementary Medicine and Therapies 2023; 23(1) doi: 10.1186/s12906-023-03975-0
|
| 27 |
Yun-yun Zhang, Pan-pan Feng, Hong-fei Wang, Heng Zhang, Tao Liang, Xiao-shan Hao, Feng-ze Wang, Hong-rong Fei. Licochalcone B induces DNA damage, cell cycle arrest, apoptosis, and enhances TRAIL sensitivity in hepatocellular carcinoma cells. Chemico-Biological Interactions 2022; 365: 110076 doi: 10.1016/j.cbi.2022.110076
|
| 28 |
Dong-hai Zheng, Jia-mei Yang, Jian-xiong Wu, Shu-qun Cheng, Shao-geng Zhang, Dong Wu, Ai-jun Li, Xiao-hui Fu, Xun Li, Fu-chen Qi, Wei-hong Duan, Jun-hui Chen, Zhi-ying Yang, Lu Liang, Jin-xiong Zeng, Wei-da Zheng, Meng-chao Wu. Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma: A Multicenter, Randomized Controlled Trial. Chinese Journal of Integrative Medicine 2023; 29(1): 3 doi: 10.1007/s11655-022-3537-4
|
| 29 |
Yuren Zhang, Hetong Zhao, Yuyu Guo, Yongbin Meng, Shasha Yu, Bo Pan, Xiaofeng Zhai. Relationship between thick or greasy tongue-coating microbiota and tongue diagnosis in patients with primary liver cancer. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.903616
|
| 30 |
Chun Li, Xin-You Pan, Mingyun Ma, Jun Zhao, Fengda Zhao, Ya-Ping Lv.
Astragalus
polysacharin inhibits hepatocellular carcinoma-like phenotypes in a murine HCC model through repression of M2 polarization of tumour-associated macrophages
. Pharmaceutical Biology 2021; 59(1): 1531 doi: 10.1080/13880209.2021.1991384
|
| 31 |
Cao Ngoc Minh Trang, Ho Nguyen Quynh Chi, Nguyen Khac Manh, Hoang Nghia Son, Dai-Nghiep Ngo, Le Thanh Long. The Chloroform Extracts of Vietnamese Sophora flavescens Ait. Inhibit the Proliferation of HepG2 Cells through Apoptosis Induction. Applied Sciences 2022; 12(12): 5906 doi: 10.3390/app12125906
|
| 32 |
Zahra Farzaneh, Maryam Farzaneh. Herbal Medicine-derived Compounds for the Prevention and Treatment of
Hepatocellular Carcinoma. Current Cancer Therapy Reviews 2022; 18(4): 230 doi: 10.2174/1573394718666220519115626
|
| 33 |
Christian Bailly. Atractylenolides, essential components of Atractylodes-based traditional herbal medicines: Antioxidant, anti-inflammatory and anticancer properties. European Journal of Pharmacology 2021; 891: 173735 doi: 10.1016/j.ejphar.2020.173735
|
| 34 |
Anping Song, Tingting Ding, Na Wei, Jieren Yang, Mingyue Ma, Shuguo Zheng, Huanhuan Jin. Schisandrin B induces HepG2 cells pyroptosis by activating NK cells mediated anti-tumor immunity. Toxicology and Applied Pharmacology 2023; 472: 116574 doi: 10.1016/j.taap.2023.116574
|
| 35 |
Yuan Zhou, Ruifeng Xue, Jinglin Wang, Haozhen Ren. Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN/AKT signaling to suppress the epithelial-mesenchymal transition. Brazilian Journal of Medical and Biological Research 2020; 53(4) doi: 10.1590/1414-431x20198882
|
| 36 |
Dou Dou, Ze-yu Zhang, Zhi-yuan Wu, Xu-dong Qiu, Xiang-gen Zhong. Aidi Injection, Compound Kushen Injection, or Kanglaite Injection: Which Is the Best Partner with Systemic Chemotherapy for Patients with HCC? A Network Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/5497041
|
| 37 |
Zhijun Li, Haiying Bao. Anti-tumor effect of Inonotus hispidus petroleum ether extract in H22 tumor-bearing mice and analysis its mechanism by untargeted metabonomic. Journal of Ethnopharmacology 2022; 285: 114898 doi: 10.1016/j.jep.2021.114898
|
| 38 |
Jianqing Yu, George G. Chen, Paul B. S. Lai. Targeting hepatocyte growth factor/c‐mesenchymal–epithelial transition factor axis in hepatocellular carcinoma: Rationale and therapeutic strategies. Medicinal Research Reviews 2021; 41(1): 507 doi: 10.1002/med.21738
|